PFG Investments’s GSK GSK Stock Holding History

PFG Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$534K	Buy	10,181 +248	+2%	+$13.1K	0.02%	637
2026 Q1	$548K	Buy	9,933 +471	+5%	+$25.5K	0.03%	561
2025 Q4	$464K	Sell	9,462 -521	-5%	-$24.3K	0.02%	596
2025 Q3	$431K	Sell	9,983 -68	-0.7%	-$2.66K	0.02%	597
2025 Q2	$386K	Buy	10,051 +16	+0.2%	+$611	0.02%	614
2025 Q1	$389K	Sell	10,035 -411	-4%	-$15K	0.02%	596
2024 Q4	$353K	Sell	10,446 -6,129	-37%	-$221K	0.02%	637
2024 Q3	$678K	Buy	16,575 +1,302	+9%	+$53.3K	0.04%	390
2024 Q2	$588K	Buy	15,273 +515	+3%	+$21.7K	0.04%	399
2024 Q1	$633K	Buy	14,758 +6,164	+72%	+$254K	0.04%	449
2023 Q4	$318K	Sell	8,594 -9,654	-53%	-$347K	0.06%	337
2023 Q3	$662K	Sell	18,248 -2,599	-12%	-$92.2K	0.12%	184
2023 Q2	$743K	Buy	20,847 +1,077	+5%	+$38.6K	0.13%	171
2023 Q1	$703K	Buy	+19,770	New	+$692K	0.14%	156

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

PFG Investments's GSK Position: Q2 2026 in Review

PFG Investments increased its GSK (GSK) stake by 2.5% in Q2 2026, buying an estimated $13.1K and bringing the position to 10,181 shares worth $534K. The position accounts for 0.02% of the portfolio, ranked #637.

PFG Investments first reported a position in GSK in Q1 2023 and has held it in 14 quarters since. The position peaked at $743K in Q2 2023. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

PFG Investments held 10,181 shares of GSK worth $534K as of Q2 2026.
PFG Investments bought 248 GSK shares in Q2 2026, an estimated $13.1K.
GSK made up 0.02% of PFG Investments's portfolio in Q2 2026, its #637 holding.
PFG Investments first reported a position in GSK in Q1 2023 and has held it in 14 quarters since.
PFG Investments's GSK position peaked at $743K in Q2 2023.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.